PUBLISHER: The Business Research Company | PRODUCT CODE: 1760743
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760743
Weight loss and obesity management refers to a structured approach aimed at reducing and maintaining body weight, especially in individuals who are overweight or obese. This process typically involves a combination of dietary modifications, physical activity, behavioral therapy, medications, and in some cases, surgical procedures. The primary goal is to enhance overall health, lower the risk of obesity-related conditions such as type 2 diabetes, cardiovascular diseases, and hypertension, and improve quality of life.
The key products and services involved in weight loss and obesity management include medications, supplements, equipment, and professional services. Weight control medications work by suppressing appetite, inhibiting fat absorption, or boosting metabolism and are available as both prescription and over-the-counter (OTC) options. These solutions are designed for various age groups, including children, adults, and the elderly. Distribution takes place through institutional and retail sales channels. The products and services are utilized across multiple industries, such as fitness centers, slimming centers, consulting services, and online weight management programs.
The weight loss and obesity management market research report is one of a series of new reports from The Business Research Company that provides weight loss and obesity management market statistics, including the weight loss and obesity management industry global market size, regional shares, competitors with the weight loss and obesity management market share, detailed weight loss and obesity management market segments, market trends, and opportunities, and any further data you may need to thrive in the weight loss and obesity management industry. This weight loss and obesity management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The weight loss and obesity management market size has grown strongly in recent years. It will grow from $237.89 billion in 2024 to $258.08 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed during the historic period can be attributed to the increasing popularity of fad diets, a rise in sedentary lifestyles, higher consumption of processed foods, the growing impact of media-driven beauty standards, and escalating demand for rapid weight loss solutions.
The weight loss and obesity management market size is expected to see strong growth in the next few years. It will grow to $354.58 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The projected growth in the forecast period is driven by a greater emphasis on preventive healthcare, heightened awareness of the long-term health risks associated with obesity, increased accessibility to personalized nutrition plans, rising interest in medically supervised weight management programs, and the growing use of fitness tracking applications. Key trends expected in this period include advancements in metabolic monitoring technology, innovations in AI-powered nutrition planning, progress in wearable fitness devices, increased investment in the research and development of anti-obesity medications, and the emergence of digital tools for managing weight.
The growing awareness of nutrition and healthy lifestyles is expected to drive the expansion of the weight loss and obesity management market. Nutrition and healthy lifestyles involve maintaining a balanced diet and engaging in regular physical activity to promote well-being and prevent chronic diseases. This heightened awareness is largely due to increasing concerns about conditions such as obesity, diabetes, and heart disease, prompting more individuals to understand the connection between diet, exercise, and chronic disease prevention. Weight loss and obesity management supports this trend by encouraging informed dietary decisions, promoting consistent physical activity, and providing wellness education through personalized programs, community efforts, and professional healthcare guidance. As a result, a more health-conscious society is emerging, with a stronger emphasis on preventive care and sustainable habits. For example, in May 2022, a survey by the International Food Information Council among 1,005 U.S. adults, including Gen Z consumers, revealed that about 52% followed a specific diet or eating pattern in 2022-up from 39% in 2021. Popular choices included clean eating (16%), mindful eating (14%), and calorie counting (13%). This increasing focus on nutrition and healthy lifestyles is contributing to the market's growth.
Leading companies in the weight loss and obesity management sector are introducing innovative products, such as dual-purpose medications designed to manage both diabetes and obesity, to improve treatment outcomes and expand market presence. These drugs help regulate blood sugar, curb appetite, boost metabolism, and reduce calorie intake, offering an integrated approach to weight and glucose control. For instance, in February 2025, Biocon Ltd., an India-based biotechnology firm, launched Liraglutide, a GLP-1 peptide, in the UK for managing type 2 diabetes and obesity. The medication is marketed as Liraglutide Biocon for diabetes and as Biolide for chronic weight management, providing an effective solution for patients seeking improved blood sugar control and sustained weight loss.
In August 2023, Eli Lilly and Company, a U.S.-based pharmaceutical firm known for its treatments in diabetes, oncology, immunology, and obesity-related diseases, acquired Versanis Bio. This acquisition aims to strengthen Lilly's portfolio in obesity and cardiometabolic care by adding innovative therapeutic options. Versanis Bio Inc. is a biotechnology company based in the U.S. that develops treatments focused on weight loss and obesity management.
Major players in the weight loss and obesity management market are F. Hoffmann-La Roche Ltd., Medtronic plc, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Olympus Corporation, Apollo Endosurgery Inc., Biocon Limited, WW International Inc., Equinox Holdings Inc., Noom Inc., Jenny Craig Inc., Nutrisystem Inc., Virta Health Corp., Allurion Technologies Inc., Atkins Nutritionals Inc., ReShape Lifesciences Inc., Nalpropion Pharmaceuticals Inc., OptiBiotix Health plc, PRISTYN CARE.
North America was the largest region in the weight loss and obesity management market in 2024. The regions covered in weight loss and obesity management report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the weight loss and obesity management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The weight loss and obesity management market consists of revenues earned by entities by providing services such as dietary and nutritional counseling, fitness and exercise programs, behavioral therapy and lifestyle coaching, medical weight loss programs, surgical weight loss procedures, meal replacement and supplement programs, online and app-based coaching services. The market value includes the value of related goods sold by the service provider or included within the service offering. The weight loss and obesity management market also includes sales of dietary supplements, meal replacements, fitness equipment, surgical devices, prescription medications, mobile health apps, and low-calorie food and beverages. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Weight Loss And Obesity Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on weight loss and obesity management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for weight loss and obesity management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The weight loss and obesity management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.